AMGEN REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS

Go back to AMGEN REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS

Amgen (AMGN) Tops Q3 EPS by 69c, Beats on Revenue; Offers FY26 Guidance

November 3, 2026 4:02 PM EST

Amgen (NASDAQ: AMGN) reported Q3 EPS of $6.45, $0.69 better than the analyst estimate of $5.76. Revenue for the quarter came in at $10.4 billion versus the consensus estimate of $10.06 billion.

GUIDANCE:

Amgen sees FY2026 EPS of $22.90-$23.70, versus the consensus of $23.02. Amgen sees... More